Cargando…
Phase I trial of WEE1 inhibition with chemotherapy and radiotherapy as adjuvant treatment, and a window of opportunity trial with cisplatin in patients with head and neck cancer: the WISTERIA trial protocol
INTRODUCTION: Patients with head and neck squamous cell carcinoma with locally advanced disease often require multimodality treatment with surgery, radiotherapy and/or chemotherapy. Adjuvant radiotherapy with concurrent chemotherapy is offered to patients with high-risk pathological features postsur...
Autores principales: | Kong, Anthony, Good, James, Kirkham, Amanda, Savage, Joshua, Mant, Rhys, Llewellyn, Laura, Parish, Joanna, Spruce, Rachel, Forster, Martin, Schipani, Stefano, Harrington, Kevin, Sacco, Joseph, Murray, Patrick, Middleton, Gary, Yap, Christina, Mehanna, Hisham |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7076237/ https://www.ncbi.nlm.nih.gov/pubmed/32184305 http://dx.doi.org/10.1136/bmjopen-2019-033009 |
Ejemplares similares
-
WEE1 Inhibitor: Clinical Development
por: Kong, Anthony, et al.
Publicado: (2021) -
Antioxidant and Cytotoxic Constituents from Wisteria sinensis
por: Mohamed, Mona A., et al.
Publicado: (2011) -
The design of a multi-arm multi-stage (MAMS) phase III randomised controlled trial comparing alternative regimens for escalating (COMPARE) treatment of intermediate and high-risk oropharyngeal cancer with reflections on the complications of introducing a new experimental ARM
por: Gaunt, Piers, et al.
Publicado: (2015) -
Feasibility of recruitment to an oral dysplasia trial in the United Kingdom
por: Nankivell, Paul, et al.
Publicado: (2012) -
Barriers to recruitment for surgical trials in head and neck oncology: a survey of trial investigators
por: Kaur, Geetinder, et al.
Publicado: (2013)